SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-100800
Filing Date
2021-08-05
Accepted
2021-08-05 16:36:34
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q syn-20210630x10q.htm   iXBRL 10-Q 1425063
2 EXHIBIT 31.1 syn-20210630xex31d1.htm EX-31.1 10552
3 EXHIBIT 32.1 syn-20210630xex32d1.htm EX-32.1 6210
9 GRAPHIC syn-20210630x10q001.jpg GRAPHIC 86085
  Complete submission text file 0001104659-21-100800.txt   5525921

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20210630.xsd EX-101.SCH 38326
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20210630_cal.xml EX-101.CAL 40206
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20210630_def.xml EX-101.DEF 140370
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20210630_lab.xml EX-101.LAB 306608
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20210630_pre.xml EX-101.PRE 268451
10 EXTRACTED XBRL INSTANCE DOCUMENT syn-20210630x10q_htm.xml XML 863935
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 211148960
SIC: 2834 Pharmaceutical Preparations